Presentation is loading. Please wait.

Presentation is loading. Please wait.

Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy  Antoine Schernberg, Pierre Blanchard, Cyrus.

Published byNguyễn Đức Modified over 6 years ago

Similar presentations

Presentation on theme: "Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy  Antoine Schernberg, Pierre Blanchard, Cyrus."— Presentation transcript:

1 Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy  Antoine Schernberg, Pierre Blanchard, Cyrus Chargari, Dan Ou, Antonin Levy, Philippe Gorphe, Ingrid Breuskin, Sarah Atallah, Alexandre Caula, Alexandre Escande, François Janot, France Nguyen, Stéphane Temam, Eric Deutsch, Yungan Tao  Clinical and Translational Radiation Oncology  Volume 12, Pages 8-15 (August 2018) DOI: /j.ctro Copyright © 2018 The Authors Terms and Conditions

2 Fig. 1a Estimated overall survival in patients with or without leukocytosis. Clinical and Translational Radiation Oncology  , 8-15DOI: ( /j.ctro ) Copyright © 2018 The Authors Terms and Conditions

3 Fig. 1b Estimated overall survival in patients with or without neutrophilia. Clinical and Translational Radiation Oncology  , 8-15DOI: ( /j.ctro ) Copyright © 2018 The Authors Terms and Conditions

4 Fig. 2a Estimated progression free survival in patients with or without leukocytosis. Clinical and Translational Radiation Oncology  , 8-15DOI: ( /j.ctro ) Copyright © 2018 The Authors Terms and Conditions

5 Fig. 2b Estimated progression free survival in patients with or without neutrophilia. Clinical and Translational Radiation Oncology  , 8-15DOI: ( /j.ctro ) Copyright © 2018 The Authors Terms and Conditions

Download ppt "Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy  Antoine Schernberg, Pierre Blanchard, Cyrus."

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages 332-384 (March.

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Prognostic Models Predicting Survival of Patients with Brain Metastases: Integration of Lactate Dehydrogenase, Albumin and Extracranial Organ Involvement.

Prognostic Models Predicting Survival of Patients with Brain Metastases: Integration of Lactate Dehydrogenase, Albumin and Extracranial Organ Involvement.
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)  Axel.

Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)  Axel.
Volume 144, Issue 1, Pages (January 2017)

Volume 144, Issue 1, Pages (January 2017)
18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy 

18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy 
Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial)  M. Yoshida, K. Muro, A. Tsuji,

Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial)  M. Yoshida, K. Muro, A. Tsuji,
Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated  Michael D. Chuong,

Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated  Michael D. Chuong,
Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.
Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M.

Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M.
Volume 64, Pages e1-e3 (January 2017)

Volume 64, Pages e1-e3 (January 2017)
P. Therasse, S. Carbonnelle, J. Bogaerts 

P. Therasse, S. Carbonnelle, J. Bogaerts 
Oral Vinorelbine and Cisplatin with Concurrent Radiotherapy After Induction Chemotherapy with Cisplatin and Docetaxel for Patients with Locally Advanced.

Oral Vinorelbine and Cisplatin with Concurrent Radiotherapy After Induction Chemotherapy with Cisplatin and Docetaxel for Patients with Locally Advanced.
Critical Reviews in Oncology / Hematology

Critical Reviews in Oncology / Hematology
Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced.

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced.
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 

Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 
Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With.

Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With.
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,

History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Local control and overall survival after frameless radiosurgery: A single center experience  Angelika Bilger, Florian Frenzel, Oliver Oehlke, Rolf Wiehle,

Local control and overall survival after frameless radiosurgery: A single center experience  Angelika Bilger, Florian Frenzel, Oliver Oehlke, Rolf Wiehle,
Clinical and Translational Radiation Oncology

Clinical and Translational Radiation Oncology

Similar presentations

Ads by Google